Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Express Scripts
Merck
AstraZeneca
Boehringer Ingelheim

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Clazosentan

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Clazosentan?

Clazosentan is an investigational drug.

There have been 8 clinical trials for Clazosentan. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2007.

The most common disease conditions in clinical trials are Subarachnoid Hemorrhage, Hemorrhage, and Vasospasm, Intracranial. The leading clinical trial sponsors are Actelion, Idorsia Pharmaceuticals Ltd., and St. Michael's Hospital, Toronto.

Recent Clinical Trials for Clazosentan
TitleSponsorPhase
Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the BrainIdorsia Pharmaceuticals Ltd.Phase 3
A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart FunctionIdorsia Pharmaceuticals Ltd.Phase 1
A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of ClazosentanIdorsia Pharmaceuticals Ltd.Phase 1

See all Clazosentan clinical trials

Clinical Trial Summary for Clazosentan

Top disease conditions for Clazosentan
Top clinical trial sponsors for Clazosentan

See all Clazosentan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Moodys
Medtronic
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.